TG Therapeutics, Inc.

TG Therapeutics, Inc. annual/quarterly net income history and growth rate from 2021 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

• TG Therapeutics, Inc. net income for the quarter ending March 31, 2026 was 19.8 M, a 290.85% increase year-over-year.
• TG Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was 443.9 M, a 289.46% increase year-over-year.
• TG Therapeutics, Inc. annual net income for 2025 was 447.2 M, a 1812.41% increase from 2024.
• TG Therapeutics, Inc. annual net income for 2024 was 23.4 M, a 84.52% increase from 2023.
• TG Therapeutics, Inc. annual net income for 2023 was 12.7 M, a 105.66% decrease from 2022.
• TG Therapeutics, Inc. annual net income for 2022 was -223.8 M.